Clinical Trials
- Immune System
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
- Lung, Diseases of the Respiratory Systems
Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327
- Ages18 years and older
- GenderBoth
- Lung
Saracatinib (AZD0530) in the Treatment of Patients with Idiopathic Pulmonary Fibrosis
- Ages40 years and older
- GenderBoth